You need to enable JavaScript to run this app.
Recon: Teva Settles Oklahoma Opioid Suit for $85M; FDA Approves Allergan’s Vraylar for Bipolar Depression
Recon
Michael Mezher
ReconMichael Mezher
ReconMichael Mezher